Abstract and keywords
Abstract (English):
To date, there is a limited amount of literature that describes the dental quality of life measures on the OHIP-49-RU scale in patients with a confirmed diagnosis of SARS-CoV-2. Therefore, this topic is relevant. Thus, the aim of this study was to study the dental quality of life indicators according to the OHIP-49-RU scale in patients with a confirmed diagnosis of SARS-CoV-2 of moderate severity, with concomitant oral co-infection. Materials and methods: a comparative analysis of quality of life indicators according to the OHIP-49-RU scale was carried out in patients with a confirmed diagnosis of SARS-CoV-2. The conclusions are drawn based on the results of the survey, in which a comparative assessment of quality of life indicators on the OHIP-49-RU scale was carried out in 90 patients aged 45 to 60 years with moderate Sars-CoV-2 with oral co-infection. Results. During the study, the following results were obtained. An analysis of the effectiveness of the use of therapeutic and prophylactic agents in patients with SARS-CoV-2 showed that the use of a 0.05% solution of chlorhexidine bigluconate in patients with Sars-CoV-2 with concomitant oral co-infection has a more pronounced antimicrobial effect, which helps to reduce the intensity of inflammatory process in the oral mucosa and periodontal tissues, improving the quality of life than with the use of Miramistin and Rotokan. Findings. The data of the conducted study will constitute an important stage for improving the quality of life in patients with SARS-CoV-2.

SARS-CoV-2, coronavirus, oral cavity, coinfection, dental plaque, aqueous chlorhexidine, miramistin, rotokan, OHIP-49-RU

1. Belocerkovskaya Yu.G., Romanovskih A.G., Smirnov I.P. COVID-19: Respiratornaya infekciya, vyzvannaya novym koronavirusom: novye dannye ob epidemiologii, klinicheskom techenii, vedenii pacientov. Consilium Medicum. 2020;3:12-20. [Yu.G. Belotserkovskaya, A.G. Romanovskikh, I.P. Smirnov. COVID-19: Respiratory infection caused by a new coronavirus: new data on epidemiology, clinical course, patient management. Consilium Medicum. 2020;3:12-20. (In Russ.)].

2. Vahrushina E.V. Kliniko-laboratornoe obosnovanie immunokorrigiruyuschey terapii bol'nyh s recidiviruyuschim aftoznym stomatitom : avtoref. dis. … kand. med.nauk. Moskva, 2012:21. [E.V. Vakhrushina. Clinical and laboratory substantiation of immunocorrective therapy in patients with recurrent aphthous stomatitis : author. dis. … cand. medical sciences. Moscow, 2012:21. (In Russ.)].

3. Lavrovskaya Ya.A., Romanenko I.G., Lavrovskaya O.M., Pridatko I.S. Kandidoz slizistoy obolochki rta pri disbioticheskih izmeneniyah. Krymskiy terapevticheskiy zhurnal. 2017;3:27-30. [Ya.A. Lavrovskaya, I.G. Romanenko, O.M. Lavrovskaya, I.S. Prydatko. Candidiasis of the oral mucosa with dysbiotic changes. Crimean therapeutic journal. 2017;3:27-30. (In Russ.)].

4. Morozova S.V., Meytel' I.Yu. Kserostomiya: prichiny i metody korrekcii. Medicinskiy sovet. 2016;1:124-128. [S.V. Morozova, I.Yu. Meitel. Xerostomia: causes and methods of correction. Medical advice. 2016;1:124-128. (In Russ.)].

5. Nikiforov V.V., Suranova T.G., Mironov A. Yu., Zabozlaev F.G. Novaya koronavirusnaya infekciya (COVID-19): etiologiya, epidemiologiya, klinika, diagnostika, lechenie i profilaktika. Moskva. 2020:48. [V.V. Nikiforov, T.G. Suranova, A.Yu. Mironov, F.G. Zabozlaev. New coronavirus infection (COVID-19): etiology, epidemiology, clinic, diagnosis, treatment and prevention. Moscow. 2020:48. (In Russ.)].

6. Al-Tawfiq J.A., Memish Z.A. Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) // Expert review of anti-infective therapy. – 2017;3:269-275. doi: 10.1080/14787210.2017.1271712.

7. Centers for Disease Control and Prevention. Coronavirus (COVID-19).

8. Carvalho T. COVID-19 Research in Brief: December, 2019 to June, 2020 // Nat Med. – 2020;26:1152-1156. DOI: 10.1038/d41591-020-00026-w

9. European Centre for Disease Prevention and Control. COVID-19.

10. Fehr A.R., Perlman S. Coronaviruses: an overview of their replication and pathogenesis // Coronaviruses. Methods in Molecular Biology. – 2015;1282:1-23. doi:10.1007/978-1-4939-2438-7_1.

11. Junqiang L. et al. CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia // Radiology. – 2020;1:18. doi: 10.1148/radiol.2020200236.

12. Huang S., Wang Wu., Li X., Ren L., Zhao J., Hu W. et al. Clinical features of patients infected with the new 2019 coronavirus in Wuhan // Lancet. – 2020;15;395(10223):497-506. DOI: 10.1016/S0140-6736(20)30183-5

13. Hui D.S.C., Zumla A. Review of severe acute respiratory syndrome: historical, epidemiological and clinical features // Infect Dis Clin North Am. – 2019;33(4):869-889. DOI: 10.1016/j.idc.2019.07.001

14. Gouilh M.A., Puechmaille S.J., Gonzalez J.P., Teeling E., Kittayapong P., Manuguerra J.C. SARS-Coronavirus ancestor's foot-prints in South-East Asian bat colonies and the refuge theory // Infection, Genetics and Evolution // 2011;11(7):1690-1702. doi:10.1016/j.meegid.2011.06.021

15. Greene J.G., Vermillion J.R. The Simplified Oral Hygiene Index // The Journal of the American Dental Association. – 1964;68(1):7-13. DOI: 10.14219/jada.archive.1964.0034

16. Koh H.W., Kim M.S., Lee J.S., Kim H., Park S.J. Changes in swine gut microbiota in response to swine epidemic diarrhea // Microbes Environ. – 2015;30(3):284-287. DOI: 10.1264/jsme2.ME15046

17. Khan A.A., Khan Z. COVID-2019-associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in the coronavirus outbreak // Bioinformatics. – 2020;1;36(13):4065-4069. DOI: 10.1093/bioinformatics/btaa28

18. Laura D., Kramer PhD., Wadsworth Center, NYSDOH. MSD Handbook.

19. Junqiang L. et al. CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia // Radiology. – 2020;1:18. doi: 10.1148/radiol.2020200236.

20. Mammen M.J., Scannapieco F.A. Oral-lung microbiome interactions in lung diseases // Periodontol 2000. – 2020;83(1):234-224. DOI: 10.1111/prd.12301

21. Petersen P.E. The World Oral Health Report 2003: continuous improvement of oral health in the 21st century-the approach of the WHO Global Oral Health Programme // Community Dent Oral Epidemiol. – 2003;31:3-23. DOI: 10.1046/j..2003.com122.x

22. The Center for Systems Science and Engineering (CSSE) at Johns Hopkins. Coronavirus COVID-19 Global Cases.

23. Coronavirus Threatens Americans With Underlying Conditions // The New York Times.

24. Coronavirus: alerte sur l’ibuprofène et autres anti-inflammatoires // Le Figaro.

25. Shour I., Massler M. Gingival disease in Postwar Italy(1945): prevalence of gingivitis in various coe groups // J AmDentAssoc. – 1947;35;2:475-482. DOI: 10.14219/jada.archive.1947.0266

26. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X. et al. A Novel Coronavirus from Patients with Pneumonia in China 2019. Novel Coronavirus Investigating and Research Team // N Engl J Med. – 2020;20;382(8):727-733. DOI: 10.1056/NEJMoa2001017

27. Zhou F., Yu T., Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study // Lancet. – 2020;395(10229):1054-1062. DOI: 10.1016/S0140-6736(20)30566-3

Login or Create
* Forgot password?